Page 1 of 1

Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) ,

Posted: Wed Jun 20, 2018 5:00 am
by D.ap
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies



As with any medication , there can be side effects ...


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291487/